You just read:

In Clinical Trials, CAR T Cell Immunotherapy Continues to Yield Complete Responses in Children & Young Adults with Relapsed and Refractory Leukemia

News provided by

The Children's Hospital of Philadelphia

Dec 03, 2016, 19:05 ET